<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04767555</url>
  </required_header>
  <id_info>
    <org_study_id>I-Peel 2021-00027</org_study_id>
    <nct_id>NCT04767555</nct_id>
  </id_info>
  <brief_title>Impact of ILM Peeling in RRD/ I-Peel</brief_title>
  <acronym>I-Peel</acronym>
  <official_title>Impact of ILM Peeling on Functional and Anatomic Outcomes of Vitrectomy for Primary Rhegmatogenous Retinal Detachment - the I-Peel Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Berner Augenklinik am Lindenhofspital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Berner Augenklinik am Lindenhofspital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Retinal detachment is associated with a substantial risk of re-detachment in 10-20% and to&#xD;
      the formation of secondary epiretinal membranes in up to 15%. Relevant postoperative vision&#xD;
      loss is encountered in many instances, primarily in consequence of macular involvement, but&#xD;
      also secondarily due to postoperative complications, namely the formation of an epiretinal&#xD;
      membrane and proliferative vitreoretinopathy. These mechanical reasons of influence can&#xD;
      potentially be prevented by ILM peeling during reattachment surgery. This, however, is not a&#xD;
      generally accepted standard of care during primary routine vitrectomy.&#xD;
&#xD;
      Two groups suffering from primary retinal detachment will be compared: the first group will&#xD;
      receive standard re-attachment vitrectomy surgery, whereas the second group will receive an&#xD;
      identical vitrectomy surgery, but with additional ILM peeling. In this study, the&#xD;
      investigators wish to assess the influence of ILM peeling on visual outcomes and&#xD;
      postoperative complications over 12 months.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 2021</start_date>
  <completion_date type="Anticipated">June 2025</completion_date>
  <primary_completion_date type="Anticipated">April 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients developing secondary epiretinal membrane formation</measure>
    <time_frame>12 months</time_frame>
    <description>Clinically significant secondary epiretinal membrane formation requiring revision surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of re-detachments in patients</measure>
    <time_frame>12 months</time_frame>
    <description>Revision surgery due to re-detachment independently of secondary epiretinal membrane formation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Best-corrected visual acuity</measure>
    <time_frame>12 months</time_frame>
    <description>Change in best-corrected visual acuity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complication rates</measure>
    <time_frame>12 months</time_frame>
    <description>Intra- and postoperative complication rates including PVR</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical times</measure>
    <time_frame>minutes (0-300)</time_frame>
    <description>How long does the surgery take</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Retinal Detachment</condition>
  <arm_group>
    <arm_group_label>ILM (inner limiting membrane) peeling</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ILM peeling adding to standard vitreous surgery in patients suffering from retinal detachment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Peeling</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>standard vitreous surgery without ILM peeling in patients suffering from retinal detachment</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ILM (inner limiting membrane) peeling</intervention_name>
    <description>The standard technique for the removal of the inner limiting membrane is a dye-assisted ILM peeling established since 20 years as the standard of care to treat vision loss due to epiretinal membranes or macular holes in eyes with an otherwise stable retina, but not during retinal detachment surgery. Other dyes may show a stronger staining effect but since there is evidence of a potential toxicity of ICG the investigators use the well-tolerated and for this purpose approved trypan blue dye Membrane Blue ® (Dorc). This intervention will be performed in addition to standard vitreoretinal re-attachment surgery.</description>
    <arm_group_label>ILM (inner limiting membrane) peeling</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  primary rhegmatogenous retinal detachment&#xD;
&#xD;
          -  of legal age (18 years or older)&#xD;
&#xD;
          -  in case of bilateral retinal detachment, only the first-affected eye will be included&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  pre-existing functional and morphological changes to the macula, hindering visual&#xD;
             recovery (amblyopia, trauma, macular degeneration)&#xD;
&#xD;
          -  advanced retinal detachment with PVR stage C2 or more&#xD;
&#xD;
          -  eyes pre-operated within six months prior to the development of RD&#xD;
&#xD;
          -  state after any vitreoretinal surgery&#xD;
&#xD;
          -  state after complicated cataract surgery, including aphakia and anterior chamber lens&#xD;
             implantation&#xD;
&#xD;
          -  patients with increased risk profiles&#xD;
&#xD;
          -  myopia magna (≥7 diopters)&#xD;
&#xD;
          -  advanced diabetic retinopathy&#xD;
&#xD;
          -  any chronic ocular or systemic inflammatory disease&#xD;
&#xD;
          -  any other proliferative systemic disease or condition associated with impaired wound&#xD;
             healing&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>110 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Justus G Garweg, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Berner Augenklinik am Lindenhofspital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Justus G Garweg, Prof. Dr.</last_name>
    <phone>0041 31 311 12 22</phone>
    <email>justus.garweg@augenklinik-bern.ch</email>
  </overall_contact>
  <reference>
    <citation>Aras C, Arici C, Akar S, Müftüoglu G, Yolar M, Arvas S, Baserer T, Koyluoglu N. Peeling of internal limiting membrane during vitrectomy for complicated retinal detachment prevents epimacular membrane formation. Graefes Arch Clin Exp Ophthalmol. 2009 May;247(5):619-23. doi: 10.1007/s00417-008-1025-y. Epub 2008 Dec 24.</citation>
    <PMID>19107502</PMID>
  </reference>
  <reference>
    <citation>Garweg JG, Bergstein D, Windisch B, Koerner F, Halberstadt M. Recovery of visual field and acuity after removal of epiretinal and inner limiting membranes. Br J Ophthalmol. 2008 Feb;92(2):220-4. Epub 2007 Nov 30.</citation>
    <PMID>18055572</PMID>
  </reference>
  <reference>
    <citation>Garweg JG, Deiss M, Pfister IB, Gerhardt C. IMPACT OF INNER LIMITING MEMBRANE PEELING ON VISUAL RECOVERY AFTER VITRECTOMY FOR PRIMARY RHEGMATOGENOUS RETINAL DETACHMENT INVOLVING THE FOVEA. Retina. 2019 May;39(5):853-859. doi: 10.1097/IAE.0000000000002046.</citation>
    <PMID>29394235</PMID>
  </reference>
  <reference>
    <citation>Höhn F, Kretz FT, Pavlidis M. [Primary vitrectomy with peeling of the internal limiting membrane under decaline: a promising surgical maneuver for treatment of total and subtotal retinal detachment]. Ophthalmologe. 2014 Sep;111(9):882-6. doi: 10.1007/s00347-014-3158-1. German.</citation>
    <PMID>25204530</PMID>
  </reference>
  <reference>
    <citation>Kodjikian L, Richter T, Halberstadt M, Beby F, Flueckiger F, Boehnke M, Garweg JG. Toxic effects of indocyanine green, infracyanine green, and trypan blue on the human retinal pigmented epithelium. Graefes Arch Clin Exp Ophthalmol. 2005 Sep;243(9):917-25. Epub 2005 Apr 15.</citation>
    <PMID>15834606</PMID>
  </reference>
  <reference>
    <citation>Koerner F, Garweg J. Advances in the management of vitreomacular traction syndrome and macular hole. Dev Ophthalmol. 1997;29:15-29. Review.</citation>
    <PMID>9413690</PMID>
  </reference>
  <reference>
    <citation>Odrobina D, Bednarski M, Cisiecki S, Michalewska Z, Kuhn F, Nawrocki J. Internal limiting membrane peeling as prophylaxis of macular pucker formation in eyes undergoing retinectomy for severe proliferative vitreoretinopathy. Retina. 2012 Feb;32(2):226-31. doi: 10.1097/IAE.0b013e31821a12e9.</citation>
    <PMID>21878849</PMID>
  </reference>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 17, 2021</study_first_submitted>
  <study_first_submitted_qc>February 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 23, 2021</study_first_posted>
  <last_update_submitted>June 4, 2021</last_update_submitted>
  <last_update_submitted_qc>June 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>retinal detachment</keyword>
  <keyword>ILM-peeling</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Retinal Detachment</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

